| Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati Vaccine 36 (17), 2262-2272, 2018 | 120 | 2018 |
| Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection R Kumar Pandey, R Ojha, A Mishra, V Kumar Prajapati Journal of cellular biochemistry 119 (9), 7631-7642, 2018 | 97 | 2018 |
| High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty International Journal of Biological Macromolecules 160, 1-17, 2020 | 95 | 2020 |
| Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product … BK Kumar, n Faheem, KVGC Sekhar, R Ojha, VK Prajapati, A Pai, ... Journal of Biomolecular Structure and Dynamics 40 (3), 1363-1386, 2022 | 82 | 2022 |
| Emerging role of circular RNAs as potential biomarkers for the diagnosis of human diseases R Ojha, R Nandani, N Chatterjee, VK Prajapati Circular RNAs: Biogenesis and Functions, 141-157, 2018 | 78 | 2018 |
| Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection R Ojha, A Pareek, RK Pandey, D Prusty, VK Prajapati ACS omega 4 (8), 13069-13079, 2019 | 69 | 2019 |
| Emerging role of circulating microRNA in the diagnosis of human infectious diseases R Ojha, R Nandani, RK Pandey, A Mishra, VK Prajapati Journal of cellular physiology 234 (2), 1030-1043, 2019 | 64 | 2019 |
| High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19 R Ojha, N Gupta, B Naik, S Singh, VK Verma, D Prusty, VK Prajapati European Journal of Pharmaceutical Sciences 151, 105375, 2020 | 59 | 2020 |
| Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic … N Chatterjee, R Ojha, N Khatoon, VK Prajapati International journal of biological macromolecules 118, 180-188, 2018 | 39 | 2018 |
| Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection RK Pandey, M Ali, R Ojha, TK Bhatt, VK Prajapati Vaccine 36 (30), 4555-4565, 2018 | 31 | 2018 |
| Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens R Ojha, RK Pandey, VK Prajapati International journal of biological macromolecules 156, 548-557, 2020 | 29 | 2020 |
| Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism N Khatoon, R Ojha, A Mishra, VK Prajapati Vaccine 36 (42), 6290-6300, 2018 | 27 | 2018 |
| Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications B Naik, VSK Mattaparthi, N Gupta, R Ojha, P Das, S Singh, VK Prajapati, ... Journal of Biomolecular Structure and Dynamics 40 (19), 9543-9567, 2022 | 25 | 2022 |
| Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins N Khatoon, RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, ... Journal of Biomolecular Structure and Dynamics 37 (9), 2381-2393, 2019 | 25 | 2019 |
| Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity R Ojha, VK Prajapati Journal of Cellular Physiology 236 (12), 8020-8034, 2021 | 21 | 2021 |
| Conglomeration of novel Culex quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections caused by blood imbibing transmitter R Ojha, N Khatoon, VK Prajapati International journal of biological macromolecules 118, 834-843, 2018 | 16 | 2018 |
| Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein–Barr virus‐associated malignancy R Ojha, R Nandani, VK Prajapati Journal of Cellular Physiology 234 (5), 6437-6448, 2019 | 13 | 2019 |
| Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2 R Ojha, K Gurjar, TS Ratnakar, A Mishra, VK Prajapati Human Immunology 83 (4), 346-355, 2022 | 12 | 2022 |
| Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria P Godara, B Naik, R Meghwal, R Ojha, V Srivastava, VK Prajapati, ... Life Sciences 311, 121121, 2022 | 10 | 2022 |
| Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection RK Pandey, R Ojha, K Dipti, R Kumar, VK Prajapati Infection, Genetics and Evolution 82, 104282, 2020 | 9 | 2020 |
Vijay K PrajapatiAssociate Professor, Department of Biochemistry, University of Delhi South CampusVerified email at south.du.ac.in
